Replacement Announcement Transaction in Own Shares

RNS Number : 5052O
Templeton Emerging Markets IT PLC
08 October 2021
 

CORRECTION ANNOUNCEMENT: Note that this is a correction announcement to replace announcement released under RNS number 2827N at 1723 hours on 28 September 2021. The announcement referred to "Ordinary shares of 25 pence each" the correct wording is now shown below. No other changes were made.

 

Stock Exchange Announcement

Templeton Emerging Markets Investment Trust PLC ("the Company")

Transaction in Own Shares

Legal Entity Identifier 5493002NMTB70RZBXO96

 

 

The Company announces that, on 28 September 2021, it purchased for cancellation 175,000 Ordinary shares of 5 pence each in the Company ("Shares") at a price of 179.33 pence per Share.

 

Following this transaction, the Company's share capital consists of 1,181,053,655 Shares in issue and 103,825,895 Shares held in Treasury. Therefore, the total number of voting rights in the Company is 1,181,053,655. In order to protect the interests of existing shareholders, shares held in treasury will only be reissued at a price above the prevailing NAV per share at the time of reissue.

 

This figure (1,181,053,655) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please e-mail   CompanySecretarialEdinburgh@franklintempleton.com  or contact Franklin Templeton Client Dealer Services via e-mail at enquiries@franklintempleton.co.uk    or via free phone 0800 305 306, +44 (0) 20 7073 8690 for overseas investors.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEANEPEFAFFEA
UK 100

Latest directors dealings